查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1555695

核心临床分子诊断市场，按产品类型、技术、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Core Clinical Molecular Diagnostics Market, By Product Type, By Technology, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 370 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年核心临床分子诊断市场规模为51.2412亿美元，2024年至2032年复合年增长率为9.65%。

核心临床分子诊断市场-市场动态

慢性病负担的上升推动了核心临床分子诊断市场的扩张

癌症、糖尿病和心血管疾病等慢性疾病的盛行率不断上升，大大增加了对分子诊断的需求。根据世界卫生组织(WHO) 的数据，非传染性疾病(NCD) 占全球死亡人数的70% 以上，其中仅癌症一项就在2020 年造成近1000 万人死亡。专注于早期检测和精准医疗，推动了分子诊断的采用。例如，美国国立卫生研究院 (NIH) 强调了分子诊断在提高疾病诊断准确性和实现标靶治疗（特别是在肿瘤学领域）方面的作用。人们越来越依赖分子诊断来管理慢性病，这凸显了其在全球医疗保健领域不断扩大的角色。

核心临床分子诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 9.65% 左右的复合年增长率成长

根据产品类型细分，预计试剂和试剂盒将在 2023 年显示最大的市场份额

从技术细分来看，聚合酶炼式反应是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

核心临床分子诊断市场-細項分析：

全球核心临床分子诊断市场根据产品类型、技术、最终用户和地区进行细分。

市场依产品类型分为三类：仪器、试剂和套件以及软体和服务。试剂和试剂盒因其在诊断过程中的重要作用而具有最高优先顺序。仪器密切跟踪，并提供测试所需的技术。软体和服务至关重要，但处于次要地位，支援营运效率。

市场依技术分为两大类：聚合酶炼式反应、次世代定序、原位杂交、微阵列和等温核酸扩增技术。聚合酶炼式反应 (PCR) 由于其广泛使用和可靠性而处于优先地位。新一代定序（NGS）因其先进的功能而紧随其后，而原位杂交、微阵列和等温核酸扩增技术（INAAT）则占据了后续位置。

核心临床分子诊断市场-地理洞察

核心临床分子诊断市场在各个地区呈现多样化的成长模式，其中北美由于其先进的医疗基础设施、尖端技术的高度采用以及对精准医疗的高度重视而处于领先地位。尤其是美国，在研发方面的大量投资以及癌症和糖尿病等慢性病的高盛行率的推动下，在市场上占据主导地位。欧洲紧随其后，德国和英国等国家因其完善的医疗保健系统和不断增加的支持分子诊断的政府倡议而做出了巨大贡献。在医疗保健支出增加、诊断基础设施改善以及早期疾病检测意识不断增强的推动下，亚太地区正在经历快速增长。值得注意的是，中国和印度因其庞大的患者群体和不断增长的个人化医疗需求而正在成为关键市场。同时，随着拉丁美洲、中东和非洲地区医疗保健系统的不断发展，儘管速度较慢，拉丁美洲和中东和非洲地区的发展势头正在逐渐增强。

核心临床分子诊断市场-竞争格局：

罗氏诊断、雅培实验室和赛默飞世尔科技等领先公司凭藉其广泛的产品组合、强大的研发能力和全球分销网络占据了市场主导地位。例如，罗氏诊断公司透过其强大的基于 PCR 的诊断产品组合和策略收购（例如收购 Stratos Genomics）保持了竞争优势。雅培实验室专注于扩大其分子诊断产品，特别是在传染病检测方面，而赛默飞世尔科技则继续利用定序和分子测定方面的先进技术进行创新。其他着名的参与者，包括 Hologic, Inc.、Qiagen NV 和 Bio-Rad Laboratories，也在透过新产品发布和合作方面取得了重大进展。新兴新创公司和小型公司不断推出颠覆性技术和新颖的诊断解决方案，从而推动老牌企业不断增强其产品，从而进一步加剧了竞争格局。

最新进展：

2021年8月，BD为美国实验室推出了全自动高通量分子诊断平台BD COR™系统。该系统透过自动化样本处理和整合各种实验室工作流程来提高子宫颈癌筛检的效率，满足诊断测试的重大需求。

2024 年 5 月，Northwell Health 在纽约成功湖开设了耗资 320 万美元的分子诊断实验室。该设施旨在增强包括 COVID-19 在内的各种疾病的检测能力，并将支持卫生系统对先进诊断服务的承诺。

目录

第 1 章：核心临床分子诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的核心临床分子诊断市场片段
    • 核心临床分子诊断市场技术片段
    • 最终用户的核心临床分子诊断市场片段
    • 按国家/地区分類的核心临床分子诊断市场片段
    • 按地区分類的核心临床分子诊断市场片段
  • 竞争洞察

第 3 章：核心临床分子诊断主要市场趋势

  • 核心临床分子诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 核心临床分子诊断市场限制
    • 市场限制影响分析
  • 核心临床分子诊断市场机会
  • 核心临床分子诊断市场未来趋势

第 4 章：核心临床分子诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：核心临床分子诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：核心临床分子诊断市场格局

  • 2023 年核心临床分子诊断市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：核心临床分子诊断市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 仪器仪表
    • 试剂和试剂盒
    • 软体与服务

第 8 章：核心临床分子诊断市场 - 按技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 聚合酶炼式反应 (PCR)
    • 新一代定序 (NGS)
    • 原位杂交
    • 微阵列
    • 等温核酸扩增技术（INAAT）

第 9 章：核心临床分子诊断市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 诊断实验室
    • 研究所
    • 学术机构

第 10 章：核心临床分子诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美核心临床分子诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲核心临床分子诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区核心临床分子诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲核心临床分子诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 核心临床分子诊断中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：关键供应商分析 - 核心临床分子诊断产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Cepheid (A Danaher Company)
    • Danaher Corporation
    • Genomic Health, Inc. (Exact Sciences)
    • Hologic, Inc.
    • Illumina, Inc.
    • Luminex Corporation
    • Myriad Genetics, Inc.
    • PerkinElmer, Inc.
    • QIAGEN NV
    • Roche Diagnostics
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3665

REPORT HIGHLIGHT

The Core Clinical Molecular Diagnostics Market size was valued at USD 5,124.12 million in 2023, expanding at a CAGR of 9.65% from 2024 to 2032.

The Core Clinical Molecular Diagnostics Market is centered around advanced techniques that analyze biological markers in the genome and proteome, facilitating precision medicine. The growing prevalence of chronic diseases, advancements in genetic sequencing technologies, and increasing demand for personalized medicine are key contributors to market growth. However, the high cost of molecular diagnostic tests and stringent regulatory requirements pose significant challenges. Opportunities abound in the expanding use of molecular diagnostics in emerging markets and the integration of AI for data analysis, which could revolutionize diagnostic accuracy. Notably, over 70% of clinical decisions are influenced by diagnostics, underscoring the critical role of molecular diagnostics in modern healthcare.

Core Clinical Molecular Diagnostics Market- Market Dynamics

Rising Chronic Disease Burden Fuels Expansion of Core Clinical Molecular Diagnostics Market

The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is significantly boosting the demand for molecular diagnostics. According to the World Health Organization (WHO), non-communicable diseases (NCDs) account for over 70% of all deaths globally, with cancer alone causing nearly 10 million deaths in 2020. This surge in chronic conditions has led to an increased focus on early detection and precision medicine, driving the adoption of molecular diagnostics. For instance, the National Institutes of Health (NIH) has highlighted the role of molecular diagnostics in improving the accuracy of disease diagnosis and enabling targeted therapies, particularly in oncology. This growing reliance on molecular diagnostics to manage chronic diseases underscores its expanding role in the global healthcare landscape.

Core Clinical Molecular Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.65% over the forecast period (2024-2032)

Based on product type segmentation, Reagents & Kits was predicted to show maximum market share in the year 2023

Based on Technology segmentation, Polymerase Chain Reaction was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Core Clinical Molecular Diagnostics Market- Segmentation Analysis:

The Global Core Clinical Molecular Diagnostics Market is segmented based on Product Type, Technology, End-User, and Region.

The market is divided into three categories based on product type: Instruments, Reagents & Kits, and Software & Services. Reagents and kits hold the highest priority due to their essential role in diagnostic procedures. Instruments are followed closely, and the necessary technology is provided for testing. Software and services are crucial but are secondary, supporting operational efficiency.

The market is divided into two categories based on Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Microarray, and Isothermal Nucleic Acid Amplification Technology. Polymerase Chain Reaction (PCR) leads in priority due to its widespread use and reliability. Next-generation sequencing (NGS) follows for its advanced capabilities, while In Situ Hybridization, Microarray, and Isothermal Nucleic Acid Amplification Technology (INAAT) occupy subsequent positions.

Core Clinical Molecular Diagnostics Market- Geographical Insights

The Core Clinical Molecular Diagnostics Market exhibits diverse growth patterns across various regions, with North America leading due to its advanced healthcare infrastructure, high adoption of cutting-edge technologies, and strong focus on precision medicine. The United States, in particular, dominates the market, driven by significant investments in research and development, coupled with a high prevalence of chronic diseases like cancer and diabetes. Europe follows closely, with countries like Germany and the UK making substantial contributions due to their well-established healthcare systems and increasing government initiatives supporting molecular diagnostics. The Asia-Pacific region is experiencing rapid growth, fueled by rising healthcare expenditures, improving diagnostic infrastructure, and a growing awareness of early disease detection. Notably, China and India are emerging as key markets due to their large patient populations and increasing demand for personalized medicine. Meanwhile, Latin America and the Middle East & Africa regions are gradually gaining momentum, albeit at a slower pace, as healthcare systems in these areas continue to develop.

Core Clinical Molecular Diagnostics Market- Competitive Landscape:

Leading companies such as Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific dominate the market, leveraging their extensive product portfolios, strong R&D capabilities, and global distribution networks. Roche Diagnostics, for instance, has maintained a competitive edge through its robust portfolio of PCR-based diagnostics and strategic acquisitions, like the purchase of Stratos Genomics. Abbott Laboratories has focused on expanding its molecular diagnostics offerings, particularly in infectious disease testing, while Thermo Fisher Scientific continues to innovate with advanced technologies in sequencing and molecular assays. Other notable players, including Hologic, Inc., Qiagen N.V., and Bio-Rad Laboratories, are also making significant strides through new product launches and collaborations. The competitive landscape is further intensified by emerging startups and smaller firms that are introducing disruptive technologies and novel diagnostic solutions, pushing established players to continuously enhance their offerings.

Recent Developments:

In August 2021, BD launched a fully automated high-throughput molecular diagnostic platform, the BD COR(TM) System, for U.S. laboratories. This system enhances efficiency in cervical cancer screening by automating sample processing and integrating various laboratory workflows, addressing significant needs in diagnostic testing.

In May 2024, Northwell Health inaugurated a USD 3.2 million molecular diagnostics laboratory in Lake Success, New York. The facility aims to enhance testing capabilities for various diseases, including COVID-19 and will support the health system's commitment to advanced diagnostic services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid (A Danaher Company)
  • Danaher Corporation
  • Genomic Health, Inc. (Exact Sciences)
  • Hologic, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Reagents & Kits
  • Software & Services

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • In Situ Hybridization
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Academic Institutions

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Core Clinical Molecular Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Core Clinical Molecular Diagnostics Market Snippet by Product Type
    • 2.1.2. Core Clinical Molecular Diagnostics Market Snippet by Technology
    • 2.1.3. Core Clinical Molecular Diagnostics Market Snippet by End-User
    • 2.1.4. Core Clinical Molecular Diagnostics Market Snippet by Country
    • 2.1.5. Core Clinical Molecular Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Core Clinical Molecular Diagnostics Key Market Trends

  • 3.1. Core Clinical Molecular Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Core Clinical Molecular Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Core Clinical Molecular Diagnostics Market Opportunities
  • 3.4. Core Clinical Molecular Diagnostics Market Future Trends

4. Core Clinical Molecular Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Core Clinical Molecular Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Core Clinical Molecular Diagnostics Market Landscape

  • 6.1. Core Clinical Molecular Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Core Clinical Molecular Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Reagents & Kits
    • 7.1.4. Software & Services

8. Core Clinical Molecular Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Polymerase Chain Reaction (PCR)
    • 8.1.3. Next-Generation Sequencing (NGS)
    • 8.1.4. In Situ Hybridization
    • 8.1.5. Microarray
    • 8.1.6. Isothermal Nucleic Acid Amplification Technology (INAAT)

9. Core Clinical Molecular Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Academic Institutions

10. Core Clinical Molecular Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Core Clinical Molecular Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Core Clinical Molecular Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Core Clinical Molecular Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Core Clinical Molecular Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Core Clinical Molecular Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Core Clinical Molecular Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Agilent Technologies, Inc.
    • 11.2.3. bioMerieux SA
    • 11.2.4. Bio-Rad Laboratories, Inc.
    • 11.2.5. Cepheid (A Danaher Company)
    • 11.2.6. Danaher Corporation
    • 11.2.7. Genomic Health, Inc. (Exact Sciences)
    • 11.2.8. Hologic, Inc.
    • 11.2.9. Illumina, Inc.
    • 11.2.10. Luminex Corporation
    • 11.2.11. Myriad Genetics, Inc.
    • 11.2.12. PerkinElmer, Inc.
    • 11.2.13. QIAGEN N.V.
    • 11.2.14. Roche Diagnostics
    • 11.2.15. Siemens Healthineers AG
    • 11.2.16. Thermo Fisher Scientific Inc.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us